Stevanato Group S.p.A. (NYSE:STVN) Shares Purchased by TimesSquare Capital Management LLC

TimesSquare Capital Management LLC boosted its position in shares of Stevanato Group S.p.A. (NYSE:STVN - Free Report) by 2.1% during the first quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 3,358,966 shares of the company's stock after acquiring an additional 70,437 shares during the period. Stevanato Group accounts for about 1.1% of TimesSquare Capital Management LLC's investment portfolio, making the stock its 27th largest position. TimesSquare Capital Management LLC owned about 1.11% of Stevanato Group worth $68,590,000 at the end of the most recent reporting period.

A number of other hedge funds have also modified their holdings of STVN. Oppenheimer Asset Management Inc. raised its position in shares of Stevanato Group by 7.8% during the first quarter. Oppenheimer Asset Management Inc. now owns 13,878 shares of the company's stock valued at $283,000 after buying an additional 1,004 shares during the last quarter. US Bancorp DE grew its stake in shares of Stevanato Group by 17.9% in the 4th quarter. US Bancorp DE now owns 8,527 shares of the company's stock worth $186,000 after buying an additional 1,295 shares in the last quarter. Advisors Capital Management LLC increased its holdings in shares of Stevanato Group by 1.0% in the 4th quarter. Advisors Capital Management LLC now owns 170,776 shares of the company's stock worth $3,721,000 after buying an additional 1,735 shares during the last quarter. Johnson Financial Group Inc. purchased a new stake in shares of Stevanato Group during the 4th quarter valued at about $41,000. Finally, Bank of New York Mellon Corp grew its position in Stevanato Group by 14.0% in the first quarter. Bank of New York Mellon Corp now owns 19,042 shares of the company's stock worth $389,000 after acquiring an additional 2,336 shares in the last quarter.

Analyst Upgrades and Downgrades

A number of equities analysts recently issued reports on the company. William Blair restated an "outperform" rating on shares of Stevanato Group in a report on Monday, June 30th. Stephens upgraded Stevanato Group to a "strong-buy" rating in a research note on Monday, April 21st. Two investment analysts have rated the stock with a hold rating, four have assigned a buy rating and one has assigned a strong buy rating to the company's stock. Based on data from MarketBeat, the stock currently has a consensus rating of "Moderate Buy" and a consensus price target of €25.70 ($29.88).

Stevanato Group Stock Performance

Shares of Stevanato Group stock remained flat at €25.53 ($29.69) during trading hours on Thursday. 118,100 shares of the company's stock were exchanged, compared to its average volume of 329,113. Stevanato Group S.p.A. has a 1-year low of €17.12 ($19.91) and a 1-year high of €26.50 ($30.81). The company has a quick ratio of 1.26, a current ratio of 1.83 and a debt-to-equity ratio of 0.22. The stock has a market cap of $7.73 billion, a price-to-earnings ratio of 50.06, a PEG ratio of 2.44 and a beta of 0.55. The company's fifty day simple moving average is €24.02 and its 200 day simple moving average is €22.20.

Stevanato Group Increases Dividend

The firm also recently announced an annual dividend, which will be paid on Thursday, July 17th. Shareholders of record on Thursday, June 5th will be paid a dividend of $0.0613 per share. This represents a yield of 0.3%. The ex-dividend date of this dividend is Thursday, June 5th. This is a boost from Stevanato Group's previous annual dividend of $0.05.

About Stevanato Group

Stevanato Group S.p.A. engages in the design, production, and distribution of products and processes to provide integrated solutions for bio-pharma and healthcare industries in Europe, the Middle East, Africa, North America, South America, and the Asia Pacific. The company operates in two segments, Biopharmaceutical and Diagnostic Solutions; and Engineering.